We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$82.3B
AUM Growth
+$4.99B
(+6.5%)
Cap. Flow
-$951M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
27.86%
Holding
1,556
New
236
Increased
477
Reduced
438
Closed
363
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.58B |
| 2 |
Meta Platforms (Facebook)
META
|
+$916M |
| 3 |
Microsoft
MSFT
|
+$619M |
| 4 |
Booking.com
BKNG
|
+$430M |
| 5 |
HCA Healthcare
HCA
|
+$426M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$672M |
| 2 |
Vale
VALE
|
+$498M |
| 3 |
Adobe
ADBE
|
+$448M |
| 4 |
IBM
IBM
|
+$410M |
| 5 |
Amazon
AMZN
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.02% |
| 2 | Consumer Discretionary | 17.56% |
| 3 | Healthcare | 16.01% |
| 4 | Communication Services | 12.74% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNT
801
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.2M | ﹤0.01% |
+243,165
| New | +$2.14M |
|
802
Pennant Group
PNTG
$1.34B
| $2.19M | ﹤0.01% |
178,497
-137,536
| -44% | -$1.75M |
|
803
Cato Corp
CATO
$66.1M
| $2.19M | ﹤0.01% |
272,572
| – | – |
|
804
Core Molding Technologies
CMT
$223M
| $2.17M | ﹤0.01% |
95,591
+24,061
| +34% | +$467K |
|
805
Netflix
NFLX
$312B
| $2.16M | ﹤0.01% |
49,000
-658,320
| -93% | -$24.2M |
|
806
NextEra Energy
NEE
$178B
| $2.15M | ﹤0.01% |
28,963
-973
| -3% | -$73.7K |
|
807
First Financial Corp
THFF
$973M
| $2.15M | ﹤0.01% |
66,083
+18,650
| +39% | +$636K |
|
|
IAS
808
DELISTED
Integral Ad Science
IAS
| $2.14M | ﹤0.01% |
118,929
-1,946
| -2% | -$32.9K |
|
809
Lam Research
LRCX
$390B
| $2.12M | ﹤0.01% |
33,030
+8,540
| +35% | +$481K |
|
|
BDN
810
Brandywine Realty Trust
BDN
$539M
| $2.12M | ﹤0.01% |
456,397
-415,865
| -48% | -$1.7M |
|
811
Merit Medical Systems
MMSI
$5.46B
| $2.12M | ﹤0.01% |
25,293
+14,065
| +125% | +$1.14M |
|
812
Kennametal
KMT
$2.33B
| $2.12M | ﹤0.01% |
74,501
+35,286
| +90% | +$946K |
|
813
FLEX LNG
FLNG
$1.59B
| $2.11M | ﹤0.01% |
+69,181
| New | +$2.21M |
|
|
NXGN
814
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.11M | ﹤0.01% |
130,158
-34,682
| -21% | -$575K |
|
815
Protolabs
PRLB
$2.17B
| $2.09M | ﹤0.01% |
59,704
+10,222
| +21% | +$326K |
|
816
HealthStream
HSTM
$849M
| $2.08M | ﹤0.01% |
84,528
-49,732
| -37% | -$1.23M |
|
817
BILL Holdings
BILL
$4.92B
| $2.07M | ﹤0.01% |
17,691
-51,379
| -74% | -$4.88M |
|
818
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $2.06M | ﹤0.01% |
52,159
+29,194
| +127% | +$1.15M |
|
819
CNA Financial
CNA
$13.9B
| $2.06M | ﹤0.01% |
53,330
-14,941
| -22% | -$582K |
|
|
DOCU
820
DocuSign
DOCU
$11.3B
| $2.05M | ﹤0.01% |
+40,108
| New | +$2.12M |
|
821
Frontline
FRO
$8.54B
| $2.05M | ﹤0.01% |
141,828
+103,005
| +265% | +$1.54M |
|
822
Financial Institutions
FISI
$821M
| $2.05M | ﹤0.01% |
130,032
+109,229
| +525% | +$1.85M |
|
|
TIO
823
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $2.04M | ﹤0.01% |
+1,683,259
| New | +$3.8M |
|
824
Hess Midstream
HESM
$5.24B
| $2.01M | ﹤0.01% |
+65,407
| New | +$1.89M |
|
825
Climb Global Solutions
CLMB
$511M
| $2M | ﹤0.01% |
+167,176
| New | +$2.04M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Arrowstreet Capital held 1,556 positions worth $82.3B, up 6.5% from $77.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Arrowstreet Capital's Q2 2023 filing shows 236 new, 477 increased, 438 reduced and 363 closed positions. Its largest new stake was D.R. Horton: 1,478,257 shares worth $180M. The largest sale was Intel, an estimated $672M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Arrowstreet Capital's largest Q2 2023 buy was D.R. Horton: 1,478,257 shares worth $180M.
- Arrowstreet Capital added most to Apple in Q2 2023, an estimated $1.58B increase.
- Arrowstreet Capital's biggest Q2 2023 reduction was Intel, cutting an estimated $672M.
- Arrowstreet Capital fully exited Vale in Q2 2023, selling an estimated $498M.
- Arrowstreet Capital's ten largest holdings make up 28% of its $82.3B portfolio in Q2 2023.
- Arrowstreet Capital opened 236 new positions and closed 363 in Q2 2023.
- Arrowstreet Capital's portfolio value rose 6.5% quarter-over-quarter to $82.3B.
Based on Arrowstreet Capital's 13F filing for Q2 2023, filed 14 Aug 2023.